Bayik Defne, Tross Debra, Haile Lydia A, Verthelyi Daniela, Klinman Dennis M
Cancer and Inflammation Program, National Cancer Institute, National Institutes of Health, Frederick MD; and.
Laboratory of Immunology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
Blood Adv. 2017 Dec 4;1(26):2510-2519. doi: 10.1182/bloodadvances.2017011221. eCollection 2017 Dec 12.
Human monocytes differentiate into either proinflammatory or immunosuppressive macrophages in response to distinct stimuli. Results show that the Toll-like receptor 2/1 agonist PAM3 replicates the ability of macrophage colony-stimulating factor (M-CSF) to induce the preferential generation of immunosuppressive macrophages in vitro, an activity confirmed by in vivo studies of rhesus macaques. By comparing the gene expression pattern of monocytes treated with M-CSF vs PAM3, the pathways regulating macrophage maturation were identified. NF-κB and Akt were found to play a central role in the overall process of monocyte into macrophage differentiation. Pathways regulated by p38 MAPK and PTGS2 biased this process toward the generation of immunosuppressive rather than proinflammatory macrophages. ERK and JNK contribute to PAM3- but not M-CSF-driven monocyte maturation. These findings clarify the mechanisms underlying the generation of immunosuppressive macrophages and support the use of PAM3 in the treatment of autoimmune and inflammatory diseases.
人类单核细胞在不同刺激下可分化为促炎或免疫抑制性巨噬细胞。结果表明,Toll样受体2/1激动剂PAM3可复制巨噬细胞集落刺激因子(M-CSF)在体外诱导优先产生免疫抑制性巨噬细胞的能力,恒河猴的体内研究证实了这一活性。通过比较用M-CSF与PAM3处理的单核细胞的基因表达模式,确定了调节巨噬细胞成熟的途径。发现NF-κB和Akt在单核细胞向巨噬细胞分化的整个过程中起核心作用。由p38丝裂原活化蛋白激酶(p38 MAPK)和前列腺素内过氧化物合酶2(PTGS2)调节的途径使这一过程倾向于产生免疫抑制性而非促炎性巨噬细胞。细胞外信号调节激酶(ERK)和c-Jun氨基末端激酶(JNK)有助于PAM3驱动而非M-CSF驱动的单核细胞成熟。这些发现阐明了免疫抑制性巨噬细胞产生的潜在机制,并支持PAM3在自身免疫性疾病和炎症性疾病治疗中的应用。